Skip to main content

Install RediHealth

Add RediHealth to your device for quick access.

  1. Click the install button in the address bar or open the browser menu.
  2. Select install RediHealth and confirm to open it in its own window.

3 min read, 3 min audio

Off-label use of medicines: what to be aware of

Off-label use means using a medicine for a condition, age group, dose or route that is not covered by its official approval. It is common, especially for children, rare diseases and cancer, and can be reasonable when evidence supports it. Because less is known or documented, it requires careful discussion of benefits and risks.

Key takeaway: Off-label use means using a medicine for a condition, age group, dose or route that is not covered by its official approval. It is common, especially for children, rare diseases and cancer, and can be reasonable when evidence supports it. Because less is known or documented, it requires careful discussion of benefits and risks.

Editorial draft: independent clinical and language review is pending. This information cannot diagnose symptoms or replace individual medical advice.

On this page

What off-label means

When a medicine is approved, the manufacturer has shown that it is effective and safe for specific uses described in the product information. Using it outside these uses is off-label. This does not make it illegal or unsafe by itself, and doctors may prescribe it where they judge it appropriate. It differs from unlicensed medicines, which have no approval at all.

Why it happens

Studies in children, pregnant women and people with rare diseases are often lacking, so doctors use medicines based on experience and smaller studies. New uses may be discovered after approval, but the manufacturer may not seek a formal extension. Some off-label uses have good evidence, while others rest on weak evidence.

Risks and uncertainties

There may be less information on correct dosing, side effects and interactions for off-label uses. Responsibility for harm and coverage by health insurance may differ, as insurers may only pay under certain conditions. The package leaflet will not mention your use, which can be worrying.

What to ask

Ask why the medicine is being recommended, what evidence supports it, what the alternatives are and what risks are known. Ask how success will be measured and when to stop. Check whether insurance covers it and who is responsible for follow-up.

Follow the prescribed dose, report side effects and tell all your healthcare providers. The leaflet still gives valuable safety advice such as interactions and warnings.

Taking it safely

Do not change doses on the basis of what others report online. Keep a list of all your medicines so that interactions can be checked, and report side effects promptly.

Practical examples

These hypothetical situations illustrate decisions and questions. They do not predict a diagnosis or treatment result.

Understanding a leaflet

Imagine your doctor prescribes a medicine for a use not listed in the leaflet. You could ask about the reasons and evidence, and request a written note about the plan.

Asking about costs

Suppose the prescription is not usually covered by your insurer. You might ask your doctor about alternatives and expected costs before starting.

Questions to ask your healthcare team

  • Is this use of the medicine backed by evidence, and is there an approved alternative?
  • What are the possible risks, and how will we monitor them?
  • Will my health insurance cover this treatment?

Questions about your health?

Talk to a volunteer doctor in a voice call. It is free and confidential.

Talk to a doctor

Don't need a doctor?

A pharmacist can advise you for free, without an appointment.

Nearest pharmacy

This guide does not replace a doctor. This page gives you health information. It does not give you a diagnosis or treatment. For that, see a doctor. In an emergency, call 112.

Sources and further reading

Original RediHealth educational article. The examples are hypothetical. This is not a reproduction of an IQWiG article or an endorsement by IQWiG.

The source material is in English. Information about German healthcare services may not apply in other countries.